ESR1 and breast carcinoma: As shown in GO analysis result, Estrogen receptor binding was ranked as No. 1, which indicated that this receptor might be one of the main drug targets for the treatment of breast cancer. It’s reported that estrogen receptor (ER) expresses in approximately 75% of breast cancers, modulating ER action has improved the survival of patients with ER-positive breast cancer49.